EAFO 2016

Dr Subramanian speaks with ecancertv at the IFHNOS 2016 session in Moscow about the work conducted by members and groups within the EAFO. He highlights the educational potential of the conference tour, with an emphasis on discussion and peer support for young doctors.

Dr Lee speaks with ecancertv at the IFHNOS 2016 session in Moscow about the potential of personalised therapy and targeted radiotherapy in treat oral and thyroid cancers. She also considers avoiding surgery to preserve the larynx of patients, depending on the course of treatment prescribed, and how earlier radiotherapy can improve voice quality over upfront surgery.

Dr Faisal speaks with ecancertv at the IFHNOS 2016 session in Moscow about the history of Shaukat Khanum Memorial Cancer Hospital. He describes the different social influences between Pakistani and Western oncology, including betel nut consumption and a lower incidence of HPV infection, and the funding of the hospital. Dr Faisal also presented his experiences with surgical outcomes in primary and redo thyroidectomies at the conference.

Prof Licitra speaks with ecancertv at the IFHNOS 2016 session in Moscow about systemic therapies for head and neck cancers. She describes efforts at integration of chemotherapy into treating local tumour indications, and surgical alternatives to chemo-radiation to reduce adverse events. Considering developments in immuno-oncology, Prof Licitra anticipates early trials which are currently ongoing will soon provide clearer steps towards a multi-modality treatment of local cancers.

Dr Dardyk speaks with ecancertv at the IFHNOS 2016 session in Moscow about founding the Eurasian Cancer Foundation. She outlines courses and content available through the ECF for supporting oncologists, clinicians and students.

Dr Smolyarchuk speaks with ecancertv at the IFHNOS 2016 session in Moscow about PET CT scanning for head and neck cancer. He describes the most suitable indications for PET CT staging of disease, and how to determine which patients may receive the greatest benefit. Dr Smolyarchuk also explains the use of PET scanning to detect metastases.

Prof Shah speaks with ecancertv at the IFHNOS 2016 session in Moscow about the global increase in thyroid cancer diagnosis. He describes how readily available, highly specific scanning systems might be accountable for this rise, with benign microsarcomas accounting for a significant portion of cancers not requiring surgical intervention.

Dr Adibay speaks with ecancertv at the IFHNOS 2016 session in Moscow about the structure and responsibilities of the Kazakh Institute of Oncology and Radiology. He outlines regional cancer rates, and reflects on the era of soviet nuclear testing in the region.

Prof Shah speaks with ecancertv at the IFHNOS 2016 session in Moscow about value and virtue of educational conference sessions among international audiences.

Prof Shah speaks with ecancertv at the IFHNOS 2016 session in Moscow about the complexity of surgery at base of the skull. He describes advances in the field, including endonasal endoscopic surgery.

Prof Bradford speaks with ecancertv at the IFHNOS 2016 session in Moscow about the growing prevalence of HPV-related throat cancers. She describes early HPV-related oral cancers as typically easier to treat, and occurring in younger patients, than those resulting from tobacco or alcohol. Prof Bradford also notes the delay between current vaccination efforts and when those patients will reach an age by which the vaccine will have proved its use, and encourages wider uptake of HPV vaccination.

Prof Cernea speaks with ecancertv at the IFHNOS 2016 session in Moscow about preservation of healthy tissues and function in treating laryngeal cancers. He describes laser microsurgery as a precision alternative to external beam radiotherapy for early tumours, with total laryngectomy as a surgery of last-resort in advanced cancers.

Prof Cernea speaks with ecancertv at the IFHNOS 2016 session in Moscow about minimising the risks associated with thyroid surgery, one of the most common in head and neck operations. He describes vigilance and anatomical awareness as key for surgeons, and outlines technological advances which enable more exact, rapid and well-tolerated removal of cancerous tissue.

Prof Bradford speaks with ecancertv at the IFHNOS 2016 session in Moscow about melanoma of the head and neck, caused by lack of protection to UV radiation from the Sun, or other sources including tanning beds. She relates the case of young boy with two positive lymph node biopsies, which can indicate metastatic spread early in tumour development.

Prof Bradford speaks with ecancertv at the IFHNOS 2016 session in Moscow about her current research, specialising in HPV-related cancer. She notes a worse prognosis for smokers with HPV, and considers the potential for virus-mediated gene disruption as a promoter of tumourigenesis.

Prof Shaha speaks with ecancertv at the IFHNOS 2016 session in Moscow about management of thyroid cancer, including early diagnosis of micro-carcinomas. He compares this to 'watchful waiting' in prostate cancer, and the risks of over-diagnosis and over-treatment.

Dr Lavrov speaks with ecancertv at the IFHNOS 2016 session in Moscow about molecular genetics aiding in diagnosis and treatment of thyroid cancer. He outlines the processes by which mutational aberrations can be detected, and how to cope with the wealth of data rendered by next-generation sequencing.

Dr Karpenko speaks with ecancertv at the IFHNOS 2016 session in Moscow about the epidemiology of cancer in the St Petersburg region. He discusses the prevalence of advanced oral cancer, to which he attributes alcohol and tobacco as driving factors, and the cancer research support within the hospital network.